A high-tech multi-use facility that provides critical infrastructure to the artificial intelligence, medtech, space, and robotics sectors is among four projects set to share in $8 million, as part of the NSW Government’s Tech Central Research and Innovation Infrastructure Fund.
Minister for Science, Innovation and Technology Alister Henskens said the successful projects will provide specialised equipment and deliver collaborative programs with a focus on existing industry and research strengths across the Tech Central Innovation District which stretches from Surry Hills to Camperdown.
“The NSW Liberal and Nationals Government is committed to translating our state’s incredible R&D capabilities into tangible outcomes that create new jobs and industries, which will grow the economy and help secure a brighter future for the people of NSW,” Mr Henskens said.
“Tech Central already boasts tech giant Atlassian as an anchor tenant, three world-leading universities, Royal Prince Alfred Hospital and over 100 research institutes.
“Its status as a nation-leading centre of innovation and development will be enhanced by these projects, harnessing the power of local expertise to bring significant physical and digital infrastructure across its target industries and research areas, from the University of Sydney, University of Technology Sydney and ARIA Research.”
Top Australian Brokers
- eToro - market-leading social trading platform - Read our review
- IG - Extensive product array and user-friendly platforms - Read our review
- IC Markets - experienced and highly regulated - Read our review
- Avatrade - powerful trading tools - Read our review
NSW Chief Scientist & Engineer Professor Hugh Durrant-Whyte said the fund brings further innovation, R&D and industry talent to Tech Central that will complement existing tenants.
“The successful applicants will accelerate the development of Tech Central as a place where people will come together to innovate, collaborate and explore new markets,” Professor Durrant-Whyte said.
“These projects, which also include a Vaccine and RNA Design Centre, have been chosen for their capacity to add to the already vibrant technological and innovative ecosystem, with the aim to realise their potential, commercialise and raise their profile locally and internationally.”
